Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02763735 · ClinicalTrials.gov registry record

Right Ventricular Metabolism in Pulmonary Arterial Hypertension

A clinical trial of Healthy and Pulmonary Arterial Hypertension, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
34
Enrollment target
1
Study location

NCT02763735 is a study of Healthy and Pulmonary Arterial Hypertension that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 34 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02763735, a study of Healthy and Pulmonary Arterial Hypertension, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
34 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to use non-invasive imaging to determine the metabolic phenotype of the right ventricle in patients with pulmonary arterial hypertension across a spectrum of disease severity.

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2014-06
Est. Completion 2019-06

What the Registry Record Tells You About NCT02763735

The ClinicalTrials.gov registry entry for NCT02763735 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT02763735 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02763735 about?

NCT02763735 is a clinical study titled "Right Ventricular Metabolism in Pulmonary Arterial Hypertension". The purpose of this study is to use non-invasive imaging to determine the metabolic phenotype of the right ventricle in patients with pulmonary arterial hypertension across a spectrum of disease severity.

What is the current status of trial NCT02763735?

This trial is currently completed. The enrollment target is 34 participants. The study started on 2014-06. Estimated completion is 2019-06.

What conditions does trial NCT02763735 study?

This clinical trial studies the following conditions: Healthy, Pulmonary Arterial Hypertension.

Who is sponsoring clinical trial NCT02763735?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02763735 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.